Stroke Risk in Atrial Fibrillation: A Moving Target?

    loading  Checking for direct PDF access through Ovid

Abstract

An investigation of patients in a national database with atrial fibrillation, no comorbidities, and not on aspirin or anticoagulants showed that the clinical features that make up the CHA2DS2-VASc score change over time and can increase a patient’s risk for stroke, which could affect therapy decisions. Thus, the CHA2DS2-VASc score should be reassessed periodically and appropriate therapeutic actions taken promptly.

Related Topics

    loading  Loading Related Articles